|
|
||||||||
Journal of Lipid Research, Vol 36, 1618-1628, Copyright © 1995 by Lipid Research, Inc.
WR Fisher, V Venkatakrishnan, LA Zech, CM Hall, LL Kilgore, PW Stacpoole, MR Diffenderfer, KE Friday, AE Sumner and JB Marsh
The kinetics of apolipoproteins A-I and A-II were examined in human
subjects using leucine tracers administered intravenously. High density
lipoproteins were separated and apoA-I and A-II were isolated. The specific
activity or enrichment data for these apolipoprotein were analyzed by
mathematical compartmental modeling. In 11 of 14 subjects studied with a
bolus-injected [3H]leucine tracer, in 3 subjects studied similarly with
[3H]leucine, and in one subject studied by primed dose, constant infusion
of [3H]leucine, a rapidly turning-over apoA-I fraction was resolved. A
similar component was observed in 7 of 10 studies of apoA-II. The apoA-I
data were analyzed using a compartmental model (Zech, L.A. et al. 1983. J.
Lipid Res. 24: 60-71) modified to incorporate plasma leucine as a precursor
for apoprotein synthesis. The data permitted resolution of two apoA-I
pools, one, C(2), turned-over with a residence time of less than 1 day, the
other, C(1), a slowly turning-over pool, appeared in plasma after a delay
of less than half a day. C(1) comprised the predominant mass of apoA-I and
was also the primary determinant of the residence time of apoA-I. Although
the mass of the fast pool, C(2), was considerably less than that of C(1),
because of its rapid turnover, the quantities of apoA-I transported through
this fast pathway were 2- to 4-fold greater. These kinetic studies indicate
that apoA-I is secreted into both fast and slowly turning-over plasma
pools. The latter is predominantly measured with radioiodinated apoA-I
tracers. The data can be analyzed by postulating either separate input
pathways to each of the pools or by assuming the fast pool is the precursor
to the slow pool. Thus, apoA-I could be initially secreted as a family of
particles that are rapidly cleared from plasma, and a portion of this
apoprotein then reappears in a slowly turning-over pool that constitutes
the major mass of apoA-I. The physiologic identity of these kinetically
distinct apoA-I species is unknown; however, the fast pool of apoA-I
demonstrated in these studies is strikingly similar to that seen in
subjects with Tangier disease who lack the slow pool.
ARTICLES
Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans
Department of Medicine, University of Florida College of Medicine, Gainesville 32610, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. H. R. Barrett, D. C. Chan, and G. F. Watts Thematic review series: Patient-Oriented Research. Design and analysis of lipoprotein tracer kinetics studies in humans J. Lipid Res., August 1, 2006; 47(8): 1607 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Sun, F. K Welty, G. G Dolnikowski, A. H Lichtenstein, and E. J Schaefer Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma Am. J. Clinical Nutrition, September 1, 2001; 74(3): 308 - 314. [Abstract] [Full Text] |
||||
![]() |
K. W. Huggins, P. L. Colvin, E. R. Burleson, K. Kelley, J. K. Sawyer, P. H. R. Barrett, L. L. Rudel, and J. S. Parks Dietary n-3 polyunsaturated fat increases the fractional catabolic rate of medium-sized HDL particles in African green monkeys J. Lipid Res., September 1, 2001; 42(9): 1457 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Maugeais, S. Braschi, K. Ouguerram, P. Maugeais, P. Mahot, B. Jacotot, D. Darmaun, T. Magot, and M. Krempf Lipoprotein Kinetics in Patients With Analbuminemia : Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1369 - 1375. [Abstract] [Full Text] |
||||
![]() |
M.N. Nanjee, J.R. Crouse, J.M. King, R. Hovorka, S.E. Rees, E.R. Carson, J.-J. Morgenthaler, P. Lerch, and N.E. Miller Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1203 - 1214. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |